Literature DB >> 18023907

Dual asymmetric centrifugation (DAC)--a new technique for liposome preparation.

Ulrich Massing1, Sanja Cicko, Vittorio Ziroli.   

Abstract

This is the first report on the use of a "dual asymmetric centrifuge (DAC)" for preparing liposomes. DAC differs from conventional centrifugation by an additional rotation of the sample around its own vertical axis: While the conventional centrifugation constantly pushes the sample material outwards, this additional rotation constantly forces the sample material towards the center of the centrifuge. This unique combination of two contra rotating movements results in shear forces and thus, in efficient homogenization. We demonstrated that it is possible to prepare liposomes by DAC, by homogenizing a rather concentrated blend of hydrogenated phosphatidylcholine and cholesterol (55:45 mol%) and 0.9% NaCl-solution, which results in a viscous vesicular phospholipid gel (VPG). The resulting VPG can subsequently be diluted to a conventional liposome dispersion. Since DAC is intended to make sterile preparations of liposomes, or to entrap toxic/radioactive compounds, the process was performed within a sealed vial. It could be shown that the DAC speed, the lipid concentration, the homogenization time and the addition of a mixing aid (glass beads) are all critical for the size of the liposomes. Optimized conditions resulted in liposomes of 60+/-5 nm and a trapping efficacy of 56+/-3.3% for the model compound calcein.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18023907     DOI: 10.1016/j.jconrel.2007.09.010

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  14 in total

1.  Targeted delivery to neuroblastoma of novel siRNA-anti-GD2-liposomes prepared by dual asymmetric centrifugation and sterol-based post-insertion method.

Authors:  Joanna E Adrian; Alexander Wolf; Annette Steinbach; Jochen Rössler; Regine Süss
Journal:  Pharm Res       Date:  2011-05-19       Impact factor: 4.200

2.  Gemcitabine treatment of rat soft tissue sarcoma with phosphatidyldiglycerol-based thermosensitive liposomes.

Authors:  Simone Limmer; Jasmin Hahn; Rebecca Schmidt; Kirsten Wachholz; Anja Zengerle; Katharina Lechner; Hansjörg Eibl; Rolf D Issels; Martin Hossann; Lars H Lindner
Journal:  Pharm Res       Date:  2014-03-06       Impact factor: 4.200

3.  Cationic/Anionic Polyelectrolyte (PLL/PGA) Coated Vesicular Phospholipid Gels (VPGs) Loaded with Cytarabine for Sustained Release and Anti-glioma Effects.

Authors:  Na Qi; Yu Zhang; Xing Tang; Aimin Li
Journal:  Drug Des Devel Ther       Date:  2020-05-12       Impact factor: 4.162

4.  Growth factor release by vesicular phospholipid gels: in-vitro results and application for rotator cuff repair in a rat model.

Authors:  Stefan Buchmann; Gunther H Sandmann; Lars Walz; Thomas Reichel; Knut Beitzel; Gabriele Wexel; Weiwei Tian; Achim Battmann; Stephan Vogt; Gerhard Winter; Andreas B Imhoff
Journal:  BMC Musculoskelet Disord       Date:  2015-04-10       Impact factor: 2.362

5.  Liposomal conjugates for drug delivery to the central nervous system.

Authors:  Frieder Helm; Gert Fricker
Journal:  Pharmaceutics       Date:  2015-04-01       Impact factor: 6.321

6.  Saturated and mono-unsaturated lysophosphatidylcholine metabolism in tumour cells: a potential therapeutic target for preventing metastases.

Authors:  Anna Raynor; Peter Jantscheff; Thomas Ross; Martin Schlesinger; Maurice Wilde; Sina Haasis; Tim Dreckmann; Gerd Bendas; Ulrich Massing
Journal:  Lipids Health Dis       Date:  2015-07-11       Impact factor: 3.876

7.  The stress regulator FKBP51: a novel and promising druggable target for the treatment of persistent pain states across sexes.

Authors:  Maria Maiarù; Oakley B Morgan; Tianqi Mao; Michaela Breitsamer; Harry Bamber; Max Pöhlmann; Mathias V Schmidt; Gerhard Winter; Felix Hausch; Sandrine M Géranton
Journal:  Pain       Date:  2018-07       Impact factor: 7.926

8.  Influence of process and formulation parameters on the preparation of solid lipid nanoparticles by dual centrifugation.

Authors:  Denise Steiner; Heike Bunjes
Journal:  Int J Pharm X       Date:  2021-06-05

9.  Preclinical In Vitro Studies with 3D Spheroids to Evaluate Cu(DDC)2 Containing Liposomes for the Treatment of Neuroblastoma.

Authors:  Friederike Hartwig; Monika Köll-Weber; Regine Süss
Journal:  Pharmaceutics       Date:  2021-06-17       Impact factor: 6.321

10.  Molecular imaging of brain localization of liposomes in mice using MALDI mass spectrometry.

Authors:  Annabelle Fülöp; Denis A Sammour; Katrin Erich; Johanna von Gerichten; Peter van Hoogevest; Roger Sandhoff; Carsten Hopf
Journal:  Sci Rep       Date:  2016-09-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.